Patients undergoing cardiac surgery are usually heavily premedicated to avoid anxiety and the consequent risk of myocardial ischaemia. The resultant respiratory depression, however, may produce arterial hypoxaemia [1] [2] [3] [4] [5] , itself risking myocardial ischaemia in patients with cardiopulmonary disease and so partly defeating the purpose of the premedication. Patients with cardiac disease may not be able to increase their coronary blood flow to compensate for arterial hypoxaemia, and may consequently suffer undetected myocardial ischaemia, which is associated with an increased incidence of perioperative myocardial infarction 6 . Prior to the inception of this study it was not our institutional practice to routinely administer supplemental oxygen following premedication.
The aim of this study was to determine the incidence of hypoxaemia in cardiac surgical patients following a combined opiate and sedative premedication, and to assess whether it is reduced by the use of supplemental oxygen. 
SUMMARY
Opiate premedication may cause significant respiratory depression, particularly when other sedative agents such as scopolamine or benzodiazepines are added. This can cause hypoxaemia with potential for worsening myocardial ischaemia in cardiac surgery patients. The aim of this study was to investigate the incidence of hypoxaemia (SpO 2 <90%) in elective patients undergoing cardiac surgery and to assess the efficacy of supplemental oxygen in preventing it.
One hundred elective patients without significant respiratory disease or cardiac failure, who received both an opiate and a sedative premedication, were prospectively randomized to receive either oxygen via a facemask at 4 l/min or no oxygen. Continuous arterial oxygen saturation was recorded using a pulse oximeter from the time of premedication until the patient arrived in theatre. An SpO 2 <90% was recorded as a significant event and oxygen was administered to the patients.
Six patients were excluded because of equipment failure or protocol violations. The patient groups were comparable with respect to patient demographics, premedication type and dose or the duration of monitoring. In patients receiving oxygen (n=48) there were no episodes of hypoxaemia (0%). In patients not receiving oxygen (n=46) there were 14 episodes of hypoxaemia (30%, P<0.0001).
We conclude that there is a significantly high incidence of hypoxaemia in cardiac surgery patients following combined opiate and sedative premedication and that it can be reduced by the routine administration of supplemental oxygen.
MATERIALS AND METHODS
The study received Institutional Ethics Committee approval. One hundred adult patients undergoing elective cardiac surgery were recruited and informed consent obtained. The premedication was prescribed by the attending anaesthetist. Only patients who were ordered both an opiate and a sedative (such as scopolamine or a benzodiazepine) premedication were included in the trial. Patients with current cardiac failure, significant respiratory dysfunction, baseline oxygen saturation below 95% on air and those undergoing emergency surgery were excluded.
Patients were prospectively randomized to receive either oxygen at 4 l/min via a facemask, or no oxygen, following premedication. The oxygen saturation, plethysmograph trace and heart rate was continuously recorded by a Nellcor N200E pulse oximeter, from premedication until arrival in the operating theatre. Patients were left undisturbed in an attempt to simulate otherwise normal preoperative conditions. A nurse was assigned to each patient for this time period. The low saturation alarm was set to 90%. Hypoxaemia was defined as an oxygen saturation of less than 90%. This value was chosen as it represents the start of the rapid desaturation phase of the haemoglobin-oxygen dissociation curve. If the nurse detected a saturation of less than 90%, oxygen was administered to the patient for the remainder of the trial period. The nurse recorded this as a hypoxaemic episode and noted the time from premedication that it occurred.
A printed copy of the information was obtained from the memory of the oximeter. Later analysis of the printed information was the primary method of artefact detection. A hypoxaemic episode was considered valid if there were simultaneous, continuous tracings of the heart rate, plethysmograph and oxygen saturation at the time of desaturation. Patients with incomplete recordings were removed from further analysis.
A power analysis was performed prior to Ethics Committee submission based on an estimated difference of 10% between groups. Patient demographic data, type of surgery, premedication administered, duration of monitoring and the incidence of hypoxaemia were recorded. Data analysis was performed following recruitment of 100 patients. Parametric data was analysed by Student's t-test. Categorical data was analysed with Chi Square or Fisher Exact tests as appropriate. A probability of P<0.05 was considered significant for all tests.
RESULTS
A total of 100 patients entered into the study. One patient was excluded due to a protocol violation and five patients were excluded because of inadequate recordings. Patient data is presented in Table 1 . With the exception of patient height (P=0.05), the patient groups were demographically comparable. The distribution of types of surgery and the premedications used were similar between groups, as was the duration of monitoring of oxygen saturation.
Fourteen of the 46 patients (30%) in the group receiving no oxygen supplementation desaturated to the critical level (SpO 2 <90%), whereas no patient of the 48 (0%) in the group receiving oxygen supplementation did (P<0.0001). The critical event, when it occurred, was 31.5±15.8 min (mean±SD) after administration of the premedication.
DISCUSSION
Previous studies have examined arterial oxygenation after premedication in patients with cardiac disease, and found that progressive desaturation and hypoxaemia occurred frequently [1] [2] [3] [4] . However, there were relatively few patients in each study, the numbers ranging from 15 to 40, and a small number of arterial samples were used to measure P a O 2 . Consequently, there was no way of knowing whether the fall in P a O 2 reflected the most severe desaturation, or whether significant hypoxaemia had been missed completely in some patients. Marjot studies examined a matched group of patients receiving oxygen to see whether this could prevent hypoxaemia. Hebbard et al 8 , using continuous pulse oximetry, compared two groups of patients with oxygen supplementation via different delivery systems and one group without oxygen supplementation, who were sedated for upper gastrointestinal endoscopy. They found that oxygen supplementation significantly decreased the incidence of critical arterial oxygen desaturation from 37% to 2%. Kavanagh et al 8 conducted a randomized, prospective study of 104 patients undergoing cardiac surgery, using continuous pulse oximetry and ECG monitoring. No attempt was made to treat hypoxaemic episodes when they occurred. In the control group (no oxygen) they demonstrated an increase in the incidence of hypoxaemia following premedication (25% to 56.9%). In the group receiving oxygen, they demonstrated a reduction but not elimination of hypoxaemic episodes (25% to 11.5%). Interestingly, there were frequent episodes where the saturation was less than 85% and three episodes less than 80%. This reinforces the principle that once saturation falls below 90%, more profound hypoxaemia can ensue rapidly. They failed to demonstrate that oxygen supplementation reduced the incidence of ECG ST depression measured by the Holter monitor.
The present study demonstrated a 30% incidence of hypoxaemia without oxygen and 0% with oxygen supplementation. The two groups were demographically comparable and each received an opiate and sedative premedication of the same average dose when normalized for body weight. In contrast to the previous study 8 , we excluded patients with baseline saturations below 95%. We believed that it was unsafe to withhold oxygen from patients with preexisting low saturations, or with congestive cardiac failure, unstable angina or requiring emergency operations. In the elective population without compromised lung function, the administration of oxygen eliminated hypoxia in this study.
The previous study 8 demonstrated that oxygen administration will not eliminate hypoxaemia, following premedication with a sedative and opiate, in a population with a high incidence of pre-existing hypoxaemia. Bottiger et al 9 studied 35 patients receiving an oral premedication of flunitrazepam and dipotassium clorazepate. Oxygen was not administered. No patient desaturated below 92%, despite adequate levels of sedation being recorded. Avoidance of opiates may be a safer premedication, especially in patients with pre-existing hypoxaemia.
Potential limitations of the study included artefactual errors related to the oximeter, such as battery failure, dislodgement of the probe or poor peripheral circulation producing an inadequate signal. A nurse was assigned to be with the patient continuously throughout the monitoring period to detect and correct these problems. A printed recording of the oximeter memory was obtained in every patient to detect signal errors and false positive measurements. Five patients were eliminated from the trial because of poor quality tracings and one patient because of protocol violations. The maximum duration of monitoring was sixty minutes because of the memory limitation of the oximeter. We are unable to determine if a longer period of monitoring would have altered the incidence of hypoxaemia.
This study demonstrates a high incidence of arterial desaturation in cardiac surgery patients who receive a combined opiate and sedative premedication, and confirms the benefit of supplemental oxygen administration. We recommend that all premedicated cardiac surgical patients receive supplemental oxygen, and that its use be considered in other patient groups.
